Change: the only constant
This article was originally published in RAJ Devices
Once again it seems that change is the only constant for the medical technology sector. Over the course of 2011, major changes will either happen or be set in train in the area of medical device and/or diagnostic regulation in the key markets of the US and the EU as well as in many smaller markets, including Australia, Malaysia, Egypt and Saudi Arabia.
You may also be interested in...
Change in leadership at the European Medicines Agency comes at a critical time.
The change in leadership at the European Medicines Agency comes at a critical time.
Another three marketing authorization applications will be fast-tracked through the centralized review process at the European Medicines Agency. The Pink Sheet tracker logs these and other developments relating to the agency's accelerated assessment mechanism.